Showing results (511-520 of 772) with videos related to

Sort By:
Pageof 78
Journal of Neurovirology|February 2, 2021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, T Allen Barnett, Breton M Asken, et al.
Molecular Therapy. Methods & Clinical Development|September 20, 2019
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral TherapyYinyan Xu, Ilana M Trumble, Joanna A Warren, et al.
International Journal of Behavioral Medicine|December 17, 2021
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and RecoveryEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
Science (New York, N.Y.)|January 18, 2024
Impact of HLA class I functional divergence on HIV controlMathias Viard, Colm O'hUigin, Yuko Yuki, et al.
Frontiers in Immunology|September 13, 2021
HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral SuppressionKai Kammers, Athena Chen, Daniel R Monaco, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Epstein Barr viral shedding dynamics in saliva during acute SARS-CoV-2 infectionMiguel A Garcia-Knight, Jessica Y Chen, Amethyst Zhang, et al.
The Journal of Clinical Investigation|April 23, 2024
Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1Gregory D Whitehill, Jaimy Joy, Francesco E Marino, et al.
Cell|December 27, 1996
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloningSamuel Davis, Thomas H Aldrich, Pamela F Jones, et al.
Plastic and Reconstructive Surgery|January 31, 2002
Reconstruction of through-and-through cheek defects involving the oral commissure, using chimeric flaps from the thigh lateral femoral circumflex systemWei-Chao Huang, Hung-Chi Chen, Vivek Jain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in UgandaJennifer Namusobya, Fred C Semitala, Gideon Amanyire, et al.
Pageof 78